Picilorex
Source: Wikipedia, the free encyclopedia.
Chemical compound
Clinical data | |
---|---|
Other names | UP 507-04 |
ATC code |
|
Identifiers | |
| |
JSmol) | |
| |
|
Picilorex (
INN; brand name Roxenan; IUPAC: 3-(4-Chlorophenyl)-5-cyclopropyl-2-methylpyrrolidine)[1] is an anorectic which is no longer marketed.[2][3][4] It is a monoamine reuptake inhibitor, a stimulant as well as a derivate of Pyrrolidine.[3]
See also
- α-PHP
- α-PHPP
- Pyrovalerone
- Prolintane
- Rolicyclidine (PCPy)
- MDPV
- List of aminorex analogues
- Substituted phenylmorpholine
References
- ^ PubChem. "Cyclopropyl-2 p-chlorophenyl-4 methyl-5 pyrrolidine succinate". pubchem.ncbi.nlm.nih.gov. Archived from the original on 2021-05-31. Retrieved 2021-05-31.
- ISBN 978-0-412-46630-4.
- ^ ISBN 978-0-566-08384-6.
- ISBN 978-0-11-986227-0. Archivedfrom the original on 2019-07-14. Retrieved 2016-10-16.
antagonists
receptor agonists
- Beloranib§
- Bimagrumab§
- Desiccated thyroid‡
- Metformin
- Metreleptin
- Naltrexone
- Setmelanotide
- Topiramate
- ZGN-1061
- Zonisamide
- Water
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III